- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Strategic Oncology Partnership Between AstraZeneca and MD Anderson
The industry-academic partnership is expected to boost clinical trials on investigational drugs and outcomes research, in gynecological cancers.
The University of Texas MD Anderson Cancer Center
has established a strategic partnership with AstraZeneca focused on ovarian and other gynecologic cancers. MD Anderson and AstraZeneca are going to conduct multiple, parallel clinical and clinically related studies with the goal of improving treatment results in oncology patients.
The collaboration is an unparalleled approach, as the two partners will be dedicated to both clinical trials on investigational treatments, and epidemiological and outcome studies. In addition to enhancing therapeutic outcomes, AstraZeneca and MD Anderson believe they can alter the way in which the industry and the academia approach research and collaborative work, as they want to deepen partnerships and accelerate the development of treatments for women with high unmet medical needs.
Link to the press release by MD ANderson: http://bit.ly/1zk7twz
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
